Molecular Diagnostics
Biomarker Found for Prostate Cancer Treatment Response
Prostate cancer is one of the most common cancers in males and has one of the highest five-year survival rate when diagnosed in the localized stage. When diagnosed in the advanced stage or when a localized tumor relapses after the initial local treatment, the usual procedure is to fight it using male hormone (androgen) deprivation therapy. More...27 Nov 2018
Childhood Epilepsy Diagnoses Shift with Genomic Reinterpretation
Clinical genomic tests that examine the DNA sequence of large numbers of genes are commonly used in the diagnosis and management of epilepsy in pediatric patients. The permanence of genomic test result interpretations is not known. More...22 Nov 2018
Genetic Basis of Childhood-Onset Cardiomyopathies Identified
Personalized medicine is one of the goals of the current medical studies, where the understanding of the genetic cause and disease mechanism in each individual will promote tailored forms of treatment. Investigators make an important step in this direction by deciphering genetic causes in children and their implications for treatment decisions. More...21 Nov 2018
Potential Brain Tumor Liquid Biopsies Developed
Liquid biopsies are fluid samples from patients, for example from the blood or urine, which provide a less invasive way to monitor disease compared to tumor biopsies. A less intrusive test could be hugely beneficial for brain tumors where collecting samples can be difficult and risky for patients. More...20 Nov 2018
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
In Other News
Microsatellite Instability Assay Validated for Cancer Studies
Genetic Test Helps Patients Avoid Unnecessary Thyroid Surgery
Herpes Simplex Virus Assay, Sample-to-Answer Instrument Get FDA Clearance
Breast Cancer Risk Variant Type Determines Tumor Aggressiveness
RNA Defects Linked to Multiple Myeloma Progression
Blood Compatibility Assay Approved by FDA
Blood Test Identifies Heart Failure with Preserved Ejection Fraction
Spinal Fluid Fingerprint Distinguishes Brain Infections from Diseases
Combined DNA Technologies Analyzed for Malaria Diagnosis
Warfarin Bleeding Risk SNPs Identified in African Americans
HPV DNA Test Monitors Remission in Oral Cancer
Ultrasensitive Screening Platform Detects Pathogenic Bacteria
Functional Genomic Landscape of AML Analyzed
Myeloproliferative Neoplasms Fall into Genetic Subgroups
Multidrug-Resistant TB Outbreak Undetected by Standard Tests
Chronic Inflammation Linked to Risk for Alzheimer's Disease
Fatal Prostate Cancer Differentiated from Manageable Cancer
High-Risk HPV Evaluated for Invasive Cervical Cancer
CD MicroRNA Marks Subtypes with Differing Outcomes
Novel Technology Enables Detection of Early-Stage Cancer
Epigenomic Method Developed to Detect Pancreatic Cancer
Multiple Myeloma Subtypes Linked to Patient Ancestry
Test Identifies More Treatable Cancer Mutations Than Biopsies
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.